Search Results

There are 137841 results for: content related to: The molecular basis of hepatitis B e antigen (HBeAg)-negative infections

  1. Interferon-α therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy

    Journal of Viral Hepatitis

    Volume 7, Issue 5, September 2000, Pages: 382–386, Heijtink, Janssen, Hop, Osterhaus and Schalm

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2893.2000.00246.x

  2. Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e41–e47, J. H. Kwon, J. W. Jang, S. Lee, J. Lee, K. W. Chung, Y. S. Lee and J. Y. Choi

    Article first published online : 20 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01509.x

  3. Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 85–93, J. L. Hou, Z. L. Gao, Q. Xie, J. M. Zhang, J. F. Sheng, J. Cheng, C. W. Chen, Q. Mao, W. Zhao, H. Ren, D. M. Tan, J. Q. Niu, S. J. Chen, C. Pan, H. Tang, H. Wang, Y. M. Mao, J. D. Jia, Q. Ning, M. Xu, S. M. Wu, J. Li, X. X. Zhang, Y. Ji, J. Dong and J. Li

    Article first published online : 22 SEP 2014, DOI: 10.1111/jvh.12313

  4. Development of a protocol for the quantitative determination of HBeAg using the Elecsys® HBeAg immunoassay

    Journal of Viral Hepatitis

    Volume 18, Issue 7, July 2011, Pages: e179–e183, K. Wursthorn, B. J. Zacher, J. Jaroszewicz, M. Darnedde, M. Manns and H. Wedemeyer

    Article first published online : 30 DEC 2010, DOI: 10.1111/j.1365-2893.2010.01419.x

  5. Replication of hepatitis B in HBsAg-positive siblings

    Journal of Viral Hepatitis

    Volume 9, Issue 4, July 2002, Pages: 272–279, Dar-in Tai, Sing Kai Lo, Chung-Huang Kuo, Jeng-Ming Du, Chiu-Jung Chen, Ching-Shu Hung and Chia-Ming Chu

    Article first published online : 25 JUN 2002, DOI: 10.1046/j.1365-2893.2002.00353.x

  6. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV–HIV-coinfected patients

    Journal of Viral Hepatitis

    Volume 19, Issue 11, November 2012, Pages: 801–810, L. Kosi, T. Reiberger, B. A. Payer, K. Grabmeier-Pfistershammer, R. Strassl, A. Rieger and M. Peck-Radosavljevic

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01601.x

  7. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients

    Journal of Viral Hepatitis

    Volume 5, Issue 4, July 1998, Pages: 241–248, A. Laras, J. Koskinas, K. Avgidis and S. J. Hadziyannis

    Article first published online : 28 FEB 2002, DOI: 10.1046/j.1365-2893.1998.00109.x

  8. Interferon-α2a for chronic hepatitis B with e antigen or antibody: comparable antiviral effects on wild-type virus and precore mutant

    Journal of Viral Hepatitis

    Volume 2, Issue 5, September 1995, Pages: 243–250, T. Aikawa, K. Kanai, M. Kako, T. Kawasaki, K. Hino, S. Iwabuchi, H. Tsubouchi, Y. Takehira, F. Tsuda, H. Okamoto, Y. Miyakawa and M. Mayumi

    Article first published online : 18 DEC 2007, DOI: 10.1111/j.1365-2893.1995.tb00036.x

  9. Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 15, Issue 11, November 2008, Pages: 817–826, D. Vassilopoulos, I. Rapti, M. Nikolaou, E. Hadziyannis and S. J. Hadziyannis

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1365-2893.2008.00996.x

  10. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis

    Journal of Viral Hepatitis

    Volume 14, Issue 3, March 2007, Pages: 169–175, J. W. Jang, Y. C. Lee, M. S. Kim, S. Y. Lee, S. H. Bae, J. Y. Choi and S. K. Yoon

    Article first published online : 2 AUG 2006, DOI: 10.1111/j.1365-2893.2006.00788.x

  11. Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants

    Journal of Viral Hepatitis

    Volume 2, Issue 2, March 1995, Pages: 77–84, W. F. Carman, M. Thursz, S. Hadziyannis, G. McIntyre, K. Colman, A. Gioustoz, G. Fattovich, A. Alberti and H. C. Thomas

    Article first published online : 18 DEC 2007, DOI: 10.1111/j.1365-2893.1995.tb00010.x

  12. Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels

    Journal of Viral Hepatitis

    Volume 19, Issue 10, October 2012, Pages: 724–731, J. W. Shin, S. W. Jung, B. R. Park, C. J. Kim, J. B. Eum, B. G. Kim, I. D. Jeong, S.-J. Bang, S.-H. Lee, S. R. Kim and N. H. Park

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01599.x

  13. Thymosin α1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study

    Journal of Viral Hepatitis

    Volume 6, Issue 5, September 1999, Pages: 397–403, M. G. Mutchnick, K. L. Lindsay, E. R. Schiff, G. D. Cummings, H. D. Appelman, R. R. Peleman, M. Silva, K. C. Roach, F. Simmons, S. Milstein, S. C. Gordon and M. N. Ehrinpreis

    Article first published online : 28 FEB 2002, DOI: 10.1046/j.1365-2893.1999.00181.x

  14. Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 138–146, Y.-C. Chen, S.-F. Huang, C.-M. Chu and Y.-F. Liaw

    Article first published online : 14 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01450.x

  15. Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 2, March 2005, Pages: 216–221, N. H. Park, J. W. Shin, J. H. Park, S-J. Bang, D-H. Kim, K. R. Joo and D. H. Kim

    Article first published online : 17 FEB 2005, DOI: 10.1111/j.1365-2893.2005.00602.x

  16. Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues

    Journal of Viral Hepatitis

    Volume 20, Issue 5, May 2013, Pages: 322–327, R. Zoutendijk, M. J. Sonneveld, J. G. P. Reijnders, A. J. van Vuuren, P. Biesta, B. E. Hansen, A. Boonstra and H. L. A. Janssen

    Article first published online : 5 DEC 2012, DOI: 10.1111/jvh.12033

  17. Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety

    Journal of Viral Hepatitis

    Volume 14, Issue 5, May 2007, Pages: 350–354, E. H. C. J. Buster, A. A. Van Der Eijk, R. A. De Man, H. L. A. Janssen and S. W. Schalm

    Article first published online : 10 NOV 2006, DOI: 10.1111/j.1365-2893.2006.00809.x

  18. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume

    Journal of Viral Hepatitis

    Volume 18, Issue 9, September 2011, Pages: 637–645, W.-M. Ke, S.-B. Xie, X.-J. Li, S.-Q. Zhang, J. Lai, Y.-N. Ye, Z.-L. Gao and P.-J. Chen

    Article first published online : 24 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01444.x

  19. Diagnosis and management of pre-core mutant chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 8, Issue 5, September 2001, Pages: 311–321, G. V. Papatheodoridis and S. J. Hadziyannis

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1365-2893.2001.00303.x

  20. You have full text access to this OnlineOpen article
    Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbation

    Journal of Viral Hepatitis

    Volume 19, Issue 3, March 2012, Pages: 161–172, C.-C. Chen, P.-C. Wang, H.-W. Chang and C.-F. Chen

    Article first published online : 4 JUL 2011, DOI: 10.1111/j.1365-2893.2011.01469.x